Predictors of long-term anti-retroviral therapy effectiveness among Brazilian HIV-1-infected children in a hybrid scenario: What really matters?

Journal of Tropical Pediatrics

Volumn 57, Issue 3, 2011, Pages 197-203

  Souza, Edvaldo S ^a   dos Santos, Nicole R ^b   Valentini, Sophia Z ^b   da Silva, Gerlane A ^a   Figueiroa, José N ^a   Falbo, Ana R ^a  

^a Instituto de Medicina Integral Prof Fernando Figueira IMIP   (Brazil)

^b Faculdade Pernambucana de Saude FPS   (Brazil)

Author keywords

Adolescent; Children; Highly active anti retroviral therapy; HIV; Treatment

Indexed keywords

COTRIMOXAZOLE; DIDANOSINE; IMMUNOGLOBULIN; LAMIVUDINE; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; ZIDOVUDINE;

ADOLESCENT; ARTICLE; CHILD; DEMOGRAPHY; DRUG EFFICACY; DRUG TREATMENT FAILURE; FEMALE; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PERINATAL PERIOD; PNEUMOCYSTOSIS; PRESCHOOL CHILD; TREATMENT DURATION; TREATMENT RESPONSE;

ADOLESCENT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BRAZIL; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INFANT; MALE; MEDICATION ADHERENCE; RESIDENCE CHARACTERISTICS; SEX FACTORS; TREATMENT OUTCOME;

EID: 79957855863     PISSN: 01426338     EISSN: 14653664     Source Type: Journal    
DOI: 10.1093/tropej/fmq082     Document Type: Article

References (32)

1. UNAIDS. Report on the Global AIDS Epidemic 2008. http://www.unaids.org (03 January 2009, date last accessed).
2. Brazil. Ministério da Saú de. Boletim Epidemiológico de AIDS- Ano V no 1 - julho a dezembro de 2007/janeiro a junho de 2008. http://www.aids.govbr. (03 January 2009, date last accessed).
3. Matida LH, Ramos AN Jr, Moncau JE, et al. Grupo Brasileiro de Estudo da Sobrevida em Crianças com AIDS. AIDS by mother-to-child transmission: survival analysis of cases followed from 1983 to 2002 in different regions of Brazil. Cad Saude Publica 2007;23(Suppl 3): S435-44.
4. Marins JR, Jamal LF, Chen SY, et al. Dramatic improvement in survival among adult Brazilian AIDS patients. AIDS 2003;17:1675-82.
5. Hacker MA, Petersen ML, Enriquez M, et al. Highly active antiretroviral therapy in Brazil: the challenge of universal access in a context of social inequality. Rev Panam Salud Publica 2004;16:78-83.
6. Dourado I, Veras MA, Barreira D, et al. AIDS epidemic trends after the introduction of antiretroviral therapy in Brazil. Rev Saude Publica 2006;40:9-17.
7. Santos EC, França I Jr, Lopes F. Quality of life of people living with HIV/AIDS in São Paulo, Brazil. Rev Saude Publica 2007;41(Suppl 2): 64-71.
8. Candiani TM, Pinto J, Cardoso CA, et al. Impact of highly active antiretroviral therapy (HAART) on the incidence of opportunistic infections, hospitalizations and mortality among children and adolescents living with HIV/AIDS in Belo Horizonte, Minas Gerais State, Brazil. Cad Saude Publica 2007;23(Suppl 3): S414-23.
9. Matida LH, Marcopito LF, Succi RC, et al. Improving survival among Brazilian children with perinatallyacquired AIDS. Braz J Infect Dis 2004;8:419-23.
10. Glikman D, Walsh L, Valkenburg J, Mangat PD, et al. Hospital-based directly observed therapy for HIV-infected children and adolescents to assess adherence to antiretroviral medications. Pediatrics 2007;119:e1142-8.
11. de Martino M, Tovo PA, Balducci M, et al. Reduction in mortality with availability of antiretroviral therapy for children with perinatal HIV-1 infection. Italian Register for HIV Infection in Children and the Italian National AIDS Registry. JAMA 2000;284:190-7.
12. Sánchez JM, Ramos Amador JT, Fernández de Miguel S, et al. Impact of highly active antiretroviral therapy on the morbidity and mortality in Spanish human immunodeficiency virus-infected children. Pediatr Infect Dis J 2003;22:863-7.
13. Judd A, Doerholt K, Tookey PA, et al. Collaborative HIV Paediatric Study (CHIPS). National Study of HIV in Pregnancy and Childhood (NSHPC). Morbidity, mortality, and response to treatment by children in the United Kingdom and Ireland with perinatally acquired HIV infection during 1996-2006: planning for teenage and adult care. Clin Infect Dis 2007;45:918-24.
14. Biadgilign S, Deribew A, Amberbir A, et al. Adherence to highly active antiretroviral therapy and its correlates among HIV infected pediatric patients in Ethiopia. BMC Pediatr 2008;8:53.
15. Barth RE, van der Meer JT, Hoepelman AI, et al. Effectiveness of highly active antiretroviral therapy administered by general practitioners in rural South Africa. Eur J Clin Microbiol Infect Dis 2008;27:977-84.
16. Patel K, Hernán MA, Williams PL, et al. Long-term effectiveness of highly active antiretroviral therapy on the survival of children and adolescents with HIV infection: a 10-year follow-up study. Clin Infect Dis 2008;46:507-15.
17. Van der Borght SF, Clevenbergh P, Rijckborst H, et al. Mortality and morbidity among HIV type-1-infected patients during the first 5 years of a multicountry HIV workplace programme in Africa. Antivir Ther 2009;14:63-74.
18. Brasil. Ministério da Saú de. Secretaria de Vigilância em Saú de. Programa Nacional de DST e Aids Recomendações para Terapia Antirretroviral em Crianças e Adolescentes Infectados pelo HIV: manual de bolso/ Ministério da Saú de, Secretaria de Vigilância em Saú de, Programa Nacional de DST e Aids.-Brasília: Ministério da Saú de, 2009. 200 p.: il. - (Sé rie Manuais, n. 85).
19. Centers for Disease Control and Prevention. 1994 Revised classification system of human immunodeficiency virus infection in children less than 13 years of age. MMWR 1994;43:1994.
20. Lemly DC, Shepherd BE, Hulgan T, et al. Race and sex differences in antiretroviral therapy use and mortality among HIV-infected persons in care. J Infect Dis 2009;199:991-8.
21. Collazos J, Asensi V, Cartón JA. Sex differences in the clinical, immunological and virological parameters of HIV-infected patients treated with HAART. AIDS 2007;21:835-43.
22. Nicastri E, Angeletti C, Palmisano L, et al. Italian Antiretroviral Treatment Group. Gender differences in clinical progression of HIV-1-infected individuals during long-term highly active antiretroviral therapy. AIDS 2005;19:577-83.
23. Souza E, Santos N, Valentini S, Silva G, et al. Long-term follow-up outcomes of perinatally hiv-infected adolescents: infection control but school failure. J Trop Pediatr 2010 [Epub ahead of print] doi:10.1093/tropej/fmq008, published on 18 February, 2010.
24. Taha TE, Nour S, Kumwenda NI, et al. Gender differences in perinatal HIV acquisition among African infants. Pediatrics 2005;115:e167-72.
25. Foca M, Moye J, Chu C, et al. Gender differences in lymphocyte populations, plasma HIV RNA levels, and disease progression in a cohort of children born to women infected with HIV. Pediatrics 2006;118:146-55.
26. European Collaborative Study. Are there gender and race differences in cellular immunity patterns over age in infected and uninfected children born to HIV-infected women? J Acquir Immune Defic Syndr 2003;33:635-41.
27. Bonolo Pde F, César CC, Acú rcio FA, et al. Non-adherence among patients initiating antiretroviral therapy: a challenge for health professionals in Brazil. AIDS 2005;19:S5-13.
28. Kekitiinwa A, Lee KJ, Walker AS, et al. Steering Committe; Mulago Cohort Team. Differences in factors associated with initial growth, CD4, and viral load responses to ART in HIV-infected children in Kampala, Uganda, and the United Kingdom/Ireland. J Acquir Immune Defic Syndr 2008;49:384-92.
29. Puthanakit T, Kerr S, Ananworanich J, et al. Pattern and predictors of immunologic recovery in human immunodeficiency virus-infected children receiving non-nucleoside reverse transcriptase inhibitor-based highly active antiretroviral therapy. Pediatr Infect Dis J 2009;28:488-92.
30. Protopopescu C, Raffi F, Roux P, et al. Factors associated with non-adherence to long-term highly active antiretroviral therapy: a 10-year follow-up analysis with correction for the bias induced by missing data. J Antimicrob Chemother 2009;64:599-606.
31. Marhefka SL, Koenig LJ, Allison S, et al. Family experiences with pediatric antiretroviral therapy: responsibilities, barriers, and strategies for remembering medications. AIDS Patient Care STDS 2008;22:637-47.
32. Merzel C, Vandevanter N, Irvine M. Adherence to antiretroviral therapy among older children and adolescents with HIV: a qualitative study of psychosocial contexts. AIDS Patient Care STDS 2008;22:977-87.